New consensus document for appropriate use of drug testing in clinical addiction medicine

June 1, 2017

A new Consensus Document from the American Society of Addiction Medicine (ASAM) provides practical, evidence-based recommendations on the use of drug testing for identification, diagnosis, treatment, and monitoring of patients with or at risk for substance use disorders (SUDs). The document appears in the May/June issue of the Journal of Addiction Medicine, the official journal of ASAM.

"Drug testing is a valuable tool for supporting patients in treatment, and this comprehensive set of recommendations should prove useful to providers in a variety of addiction treatment settings," comments Margaret Jarvis, MD, DFASAM, Chair of ASAM's Quality Improvement Council. The Consensus Document and supplemental digital content are available on Journal of Addiction Medicine and ASAM websites.

Evidence-Based Recommendations Aim at 'Smarter' Approach to Drug Testing

The Consensus Document provides practical guidance on the use of across the many clinical settings in which addiction treatment is provided. Based on evidence from more than 100 research studies, the document's recommendations were developed by a multidisciplinary panel, following an established "Appropriateness Method" process that combines scientific evidence with the collective judgment of experts.

The resulting recommendations focus on "when, where and how often it is appropriate to perform testing" in clinical . Based on evidence that drug testing aids in monitoring adherence and abstinence in treatment and can improve patient outcomes, drug testing "should be widely used in addiction treatment settings." Drug testing should serve as a therapeutic tool, rather than a punitive one: "Providers should utilize drug testing to explore denial, motivation, and actual substance use behaviors with patients."

Drug testing plays important roles in initial assessment, treatment planning, and monitoring of patients with SUDs, across treatment settings. However, the document emphasizes, "Drug testing should be only one of several methods of detecting substance use or monitoring treatment," including patient self-reports and other indicators.

The Consensus Document addresses a wide range of daily issues encountered in the process of drug testing, including the choice of tests and appropriate response to test results. Urine tests remain by far the most common category of tests, but are also the most prone to tampering. There is growing interest in using other types of samples for drug testing, although more evidence on these tests is needed.

Drug testing should be done at least weekly at the beginning of treatment, and at least monthly in patients in stable recovery; however, individual consideration may be given for less frequent testing if a patient is in stable recovery. The document recommends that testing be performed on a random schedule, when possible.

The document addresses many other elements of testing programs, including documentation and patient confidentiality, practitioner education and expertise, and facilities and devices. Issues in inpatient and outpatient treatment as well as opioid treatment services are discussed, along with issues related to special populations, including adolescents, pregnant , people in recovery, and health and other professionals. The expert panel also makes recommendations for further research to address gaps in each area.

A previous ASAM White Paper made broad suggestions to improve drug testing in clinical practice, emphasizing a "smarter" approach to drug testing—including avoiding some inappropriate and high-cost practices followed in the past. "The current crisis has many people in desperate need of high-quality addiction care, but many, professionals included, have no way of judging the quality of this kind of ," comments Dr. Jarvis. "This helps to define that high-quality care."

Explore further: Medications to treat opioid use disorders—new guideline from the American Society of Addiction Medicine

More information: undefined undefined. Appropriate Use of Drug Testing in Clinical Addiction Medicine, Journal of Addiction Medicine (2017). DOI: 10.1097/ADM.0000000000000322

Related Stories

Medications to treat opioid use disorders—new guideline from the American Society of Addiction Medicine

September 24, 2015
Medications play an important role in managing patients with opioid use disorders, but there are not enough physicians with the knowledge and ability to use these often-complex treatments. New evidence-based recommendations ...

Opioid use disorder in pregnancy—Medication treatment improves outcomes for mothers and infants

April 14, 2017
Medication for addiction treatment (MAT) with buprenorphine or methadone is an appropriate and accepted treatment for pregnant women with opioid use disorder (OUD), according to a research review and update in the Journal ...

Longer addiction treatment is better, study confirms

March 4, 2017
(HealthDay)—The longer patients receive treatment for addiction, the greater their chances of success, a new study finds.

Study explores drug users' opinions on genetic testing

September 23, 2014
Genomic medicine is rapidly developing, bringing with its advances promises of individualized genetic information to tailor and optimize prevention and treatment interventions. Genetic tests are already guiding treatments ...

Good outcomes with 'telepsychiatry' in medical treatment of opioid use disorder

January 25, 2017
For people with opioid use disorder receiving medication treatment with buprenorphine, a telepsychiatry approach—using videoconferencing as an alternative to in-person group sessions—provides similar clinical outcomes, ...

Use of psychosocial treatments in conjunction with medication for opioid addiction—recommended, but research is sparse

January 26, 2016
Psychosocial interventions, used together with effective medications, are a key part of recommended treatment for opioid addiction. But while research generally supports the effectiveness of psychosocial treatments, there ...

Recommended for you

Study finds medical cannabis is effective at reducing opioid addiction

November 17, 2017
A new study conducted by researchers at The University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection between having the legal ability to use ...

Insomnia linked to alcohol-use frequency among early adolescents, says new psychology study

November 8, 2017
Insomnia is linked to frequency of alcohol use among early adolescents, according to new Rutgers University–Camden research.

Large declines seen in teen substance abuse, delinquency

October 25, 2017
More than a decade of data indicates teens have become far less likely to abuse alcohol, nicotine and illicit drugs, and they also are less likely to engage in delinquent behaviors, such as fighting and stealing, according ...

Trying to get sober? NIH offers tool to help find good care

October 3, 2017
The phone calls come—from fellow scientists and desperate strangers—with a single question for the alcohol chief at the National Institutes of Health: Where can my loved one find good care to get sober?

Medical students need training to prescribe medical marijuana

September 15, 2017
Although 29 states and the District of Columbia allow marijuana use for medical purposes, few medical students are being trained how to prescribe the drug. Researchers at Washington University School of Medicine in St. Louis ...

Protein links alcohol abuse and changes in brain's reward center

September 8, 2017
When given access to alcohol, over time mice develop a pattern similar to what we would call "problem drinking" in people, but the brain mechanisms that drive this shift have been unclear. Now a team of UC San Francisco researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.